Abstract
Efforts to decrease the use of extended-spectrum cephalosporins are required to prevent the selection and transmission of multi-drug resistant pathogens, such as extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. The objectives of this study were to assess the clinical efficacy of intravenous cefuroxime as an empirical antibiotic for the treatment of hospitalized women with acute pyelonephritis (APN) caused by Escherichia coli. We analyzed the clinical and microbiologic database of 328 hospitalized women with community-onset APN. Of 328 women with APN, 22 patients had cefuroxime-resistant E. coli APN, and 306 patients had cefuroxime-susceptible E. coli APN. The early clinical success rates were significantly higher (p = 0.001) in the cefuroxime-susceptible group (90.8%, 278/306) than in the cefuroxime-resistant group (68.2%, 15/22) at 72 hours. The clinical cure rates at 4 to 14 days after completing antimicrobial therapy were not significantly different in the cefuroxime-resistant or -susceptible groups, with 88.2% (15/17) and 97.8% (223/228; p = 0.078), respectively. The microbiological cure rates were not significantly different and were 90.9% (10/11) and 93.4% (128/137), respectively (p = 0.550). The median ...Continue Reading
References
Jul 1, 1977·Antimicrobial Agents and Chemotherapy·R N JonesC Thornsberry
Mar 1, 1976·Antimicrobial Agents and Chemotherapy·C H O'CallaghanJ E Thornton
Jan 1, 1980·Current Medical Research and Opinion·A P RobertsR B Sykes
Oct 6, 1997·Infectious Disease Clinics of North America·A R Ronald, G K Harding
Feb 19, 2002·International Journal of Antimicrobial Agents·Kurt G NaberHans C Salmen
Jul 12, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Victor L YuUNKNOWN International Pneumococcal Study Group
May 27, 2005·The Journal of Antimicrobial Chemotherapy·Johann D D PitoutLaurent Poirel
Aug 10, 2005·Seminars in Respiratory and Critical Care Medicine·Jan E Patterson
Feb 24, 2006·The Journal of Antimicrobial Chemotherapy·Esther CalboJavier Garau
Dec 10, 2009·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jesús Rodríguez-BañoUNKNOWN Spanish Network for Research in Infectious Diseases (REIPI)
Jun 29, 2010·International Journal of Antimicrobial Agents·Cheol-In KangUNKNOWN Korean Network for Study of Infectious Diseases (KONSID)
Dec 22, 2011·Yonsei Medical Journal·Seung-Kwan LimYoung Hwa Choi
Mar 7, 2012·Antimicrobial Agents and Chemotherapy·Jae Hyun JeonHong Bin Kim
Mar 10, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Jaehyun ShinHyunjoo Pai
Mar 12, 2013·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Seong-Heon WieU-Im Chang
Citations
Jan 21, 2020·Journal of Medical Microbiology·Sara ThønningsNiels Frimodt-Møller
Jun 11, 2020·Antibiotics·Beata Zalewska-Piątek, Rafał Piątek
Apr 11, 2018·Infection & chemotherapy·Cheol In KangSeong Heon Wie
Sep 2, 2017·Frontiers in Microbiology·Maria E TerlizziMassimo E Maffei
Mar 15, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Si-Ho KimKyong Ran Peck
Sep 24, 2019·Annals of Emergency Medicine·Brit LongMichael D April